Aarti Drugs logo

Aarti Drugs CEO, MD, chairman, board of directors and AGM

NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap

Last close ₹374.90down ₹5.15 (1.36%)BSE ₹374.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹380.05.

52-week range of traded prices to 23 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
Market cap
₹3,422 Cr930th largest listed
P/E
17.9
P/B
2.2
Dividend yield
0.53%
ROE
13.1%
ROCE
12.4%
Debt to equity
0.37
Volume, NSE
1,93,03662.0% delivered

Aarti Drugs board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing director and CEOPrakash Moreshwar Patil
  • Managing directorRashesh Chandrakant Gogri
  • Managing directorHarshit Manilal Savla
  • Company Secretary and Compliance OfficerRushikesh Deole

12 directors6 independent5 executive1 non-executive

  • Prakash Moreshwar Patil · Chairperson and managing director and CEOExecutive · joined Jan 1985 · reappointed Jun 2022 · 1 listed board · 1 committee seat
  • Rashesh Chandrakant Gogri · Managing directorExecutive · joined Aug 2012 · reappointed Oct 2022 · 3 listed boards · 3 committee seats
  • Harshit Manilal Savla · Managing directorExecutive · joined Jan 1987 · reappointed Sep 2025 · 1 listed board · 1 committee seat
  • Harit Pragji ShahExecutive · joined Sep 1995 · reappointed Sep 2023 · 1 listed board · 1 committee seat
  • Nilesh Bhalchandra PatilExecutive · joined Sep 2026 · 1 listed board
  • Narendra Jagannath SalviNon-executive · joined Aug 2020 · reappointed Sep 2024 · 2 listed boards · 3 committee seats
  • Ankit Vikram PalejaIndependent · joined Oct 2021 · reappointed Oct 2024 · 59 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 2 as chair
  • Bhaskar Narayan ThoratIndependent · joined May 2022 · reappointed May 2025 · 52 months as independent · 1 listed board · 1 as independent
  • Neha Rajen GadaIndependent · joined May 2022 · reappointed May 2025 · 52 months as independent · 4 listed boards · 4 as independent · 7 committee seats, 1 as chair
  • Hasmukh Bhavanji DedhiaIndependent · joined Mar 2024 · reappointed Mar 2024 · 30 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 2 as chair
  • Ajit Eledath VenugopalanIndependent · joined Mar 2024 · reappointed Mar 2024 · 30 months as independent · 2 listed boards · 2 as independent · 3 committee seats
  • Sandeep Madhusudan JoshiIndependent · joined Mar 2024 · reappointed Mar 2024 · 30 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Uday Moreshwar Patil, left 26 Sep 2026: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 27 Aug 202611 of 12 present5 independent · 26 days in between
    • 31 Jul 202611 of 12 present6 independent · 76 days in between
    • 15 May 202610 of 12 present5 independent · 34 days in between
    • 10 Apr 202612 of 12 present6 independent
  • Audit Committee

    Chair Hasmukh Bhavanji Dedhia

    Ankit Vikram Paleja, Neha Rajen Gada, Ajit Eledath Venugopalan, Prakash Moreshwar Patil, Rashesh Chandrakant Gogri

    • 31 Jul 20266 of 6 present4 independent · 76 days in between
    • 15 May 20266 of 6 present4 independent
  • Nomination and remuneration committee

    Chair Neha Rajen Gada

    Bhaskar Narayan Thorat, Ankit Vikram Paleja, Prakash Moreshwar Patil

    • 27 Aug 20263 of 4 present2 independent · 26 days in between
    • 31 Jul 20264 of 4 present3 independent · 76 days in between
    • 15 May 20264 of 4 present3 independent
  • Stakeholders Relationship Committee

    Chair Ankit Vikram Paleja

    Narendra Jagannath Salvi, Harshit Manilal Savla, Harit Pragji Shah

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Prakash Moreshwar Patil

    Rashesh Chandrakant Gogri, Harit Pragji Shah, Harshit Manilal Savla, Narendra Jagannath Salvi, Bhaskar Narayan Thorat, Ankit Vikram Paleja, Adhish Prakash Patil, Dhanaji Laxman Kakade

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair Bhaskar Narayan Thorat

    Prakash Moreshwar Patil, Rashesh Chandrakant Gogri

    No meeting listed in the filing.

  • Finance and Investment Committee

    Chair Prakash Moreshwar Patil

    Rashesh Chandrakant Gogri, Harit Pragji Shah, Harshit Manilal Savla, Uday Moreshwar Patil

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Gokhale & Sathe, Chartered AccountantsPeer-review certificate valid to Feb 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Aarti Drugs AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Aarti Drugs dividend history

Annual general meeting, 26 Sep 2026

1,43,365 shareholders on the register on 19 Sep 2026; present: 39 promoters and 54 others; votes counted by CS Monali Bhandari / Mehta & Mehta, Practicing Company Secretaries.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 74.01% · promoters 100.00% · institutions 91.21% · other public 25.10%

  2. Approval to the Retirement of Shri Uday M. Patil (DIN: 01186406) who retires by rotation and has not offered himself for re-appointment as a Director of the Company.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  3. Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Director of the Company.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  4. Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Whole-time Director of the Company
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  5. Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Director of the Company.
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.08% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  6. Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Managing Director of the Company.
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 0.87% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  7. Re-appointment of Shri Harshit Manilal Savla (DIN: 00005340) as the Joint Managing Director of the Company.
    Ordinary
    99.82% for0.18% against

    Against: promoters 0.00% · institutions 1.13% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  8. Re-appointment of Shri Harit Pragji Shah (DIN: 00005501) as the Whole-time Director of the Company.
    Ordinary
    99.82% for0.18% against

    Against: promoters 0.00% · institutions 1.13% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  9. Re-appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company for the second term of 5 (five) years.
    Special
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 0.53% · other public 0.08%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  10. Re-appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company for the second term of 5 (five) years.
    Special
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.27% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  11. Re-appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director of the Company for the second term of 5 (five) years.
    Special
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 0.53% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  12. Approval to Shri Prakash Moreshwar Patil, a Related Party, to hold an Office or Place of Profit in the Company.
    Ordinary
    97.85% for2.15% against

    Against: promoters 0.00% · institutions 11.01% · other public 0.09%

    Turnout: all 58.18% · promoters 70.88% · institutions 91.37% · other public 25.10%

  13. Payment of Profit Related Commission to the Nonexecutive Directors.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  14. Aarti Drugs Limited Performance Stock Option Plan 2026 (PSOP 2026).
    Special
    84.79% for15.21% against

    Against: promoters 0.00% · institutions 99.75% · other public 0.08%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  15. Grant of stock options under Aarti Drugs Limited Performance Stock Option Plan 2026 (PSOP 2026) to the Employees of the Subsidiary Companies, Group Companies and Associate Companies (Present or Future).MoreLess
    Special
    84.79% for15.21% against

    Against: promoters 0.00% · institutions 99.75% · other public 0.09%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

  16. Ratification of remuneration of Cost Auditors for FY 2026-27.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 74.02% · promoters 100.00% · institutions 91.37% · other public 25.10%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 24 Sep 2025, 5 resolutions

1,56,630 shareholders on the register on 17 Sep 2025; present: 36 promoters and 63 others; votes counted by CS Ronak Kalathiya / Mehta & Mehta, Practicing Companies Secretaries.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the Reports of the Board of Directors' and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 74.58% · promoters 99.86% · institutions 90.42% · other public 25.99%

  2. To appoint a Director in place of Shri Harshit Manilal Savla (DIN: 00005340), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.12% · other public 0.28%

    Turnout: all 74.59% · promoters 99.86% · institutions 90.54% · other public 25.99%

  3. Revision in the terms And conditions of appointment of Executive Directors.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.09%

    Turnout: all 74.59% · promoters 99.86% · institutions 90.54% · other public 25.99%

  4. Appointment of Secretarial Auditor for the period of 5 Consecutive Financial Years.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.03%

    Turnout: all 74.59% · promoters 99.86% · institutions 90.54% · other public 25.99%

  5. Ratification of remuneration of Cost Auditors for FY 2025-26.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 74.59% · promoters 99.86% · institutions 90.54% · other public 25.99%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 20 Sep 2024, 7 resolutions

Present: 71 promoters and 60 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with the Reports of the Board of Directors¿ and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 65.61% · promoters 87.27% · institutions 87.17% · other public 23.84%

  2. To appoint a Director in place of Shri Narendra Jagannath Salvi (DIN: 00299202), who is liable to retire by rotation and being eligible, offers himself for re-appointment
    Ordinary
    98.25% for1.75% against

    Against: promoters 0.00% · institutions 12.90% · other public 0.02%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

  3. Re-appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director
    Special
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.88% · other public 0.04%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

  4. Re-appointment of Shri Bhaskar Narayan Thorat (DIN: 01293824) as an Independent Direct
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.91% · other public 0.02%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

  5. Re-appointment of Smt. Neha Rajen Gada (DIN: 01642373) as an Independent Director
    Special
    90.92% for9.08% against

    Against: promoters 0.00% · institutions 66.88% · other public 0.04%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

  6. Revision in the terms & conditions of appointment of Shri Uday Moreshwar Patil (DIN: 01186406), Executive Director of the Company
    OrdinaryPromoters have an interest in it
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.86% · other public 0.02%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

  7. Ratification of remuneration of Cost Auditors for FY 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 65.62% · promoters 87.27% · institutions 87.32% · other public 23.84%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 15 Jun 2024, 3 resolutions

The company's voting result (opens in a new tab)

  1. Approval to the appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.15%

    Turnout: all 70.16% · promoters 99.92% · institutions 76.77% · other public 18.70%

  2. Approval to the appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director of the Company.
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 70.16% · promoters 99.92% · institutions 76.77% · other public 18.70%

  3. Approval to the appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 70.16% · promoters 99.92% · institutions 76.77% · other public 18.70%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 26 Sep 2023, 5 resolutions

Present: 37 promoters and 60 others.The company's voting result (opens in a new tab)

  1. Adoption of Financial Statement (Standalone & Consolidated) for the Financial Year ended March 31, 2023, together with the Reports of the Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 73.45% · promoters 99.97% · institutions 88.16% · other public 24.04%

  2. Re-appointment of Shri Harit P.Shah (DIN: 00005501), who retires by rotation and being eligible, seeks re-appointment.
    Ordinary
    97.97% for2.03% against

    Against: promoters 0.00% · institutions 21.44% · other public 0.05%

    Turnout: all 70.79% · promoters 99.97% · institutions 88.34% · other public 16.12%

  3. Appointment of Gokhale & Sathe, Chartered Accountants as Statutory Auditors of the Company
    Ordinary
    93.02% for6.98% against

    Against: promoters 0.00% · institutions 76.53% · other public 0.02%

    Turnout: all 73.46% · promoters 99.97% · institutions 88.34% · other public 24.04%

  4. Approval to Smt Richie Gandhi to continue to hold office or place of profit with revised Remuneration.
    Ordinary
    97.79% for2.21% against

    Against: promoters 0.00% · institutions 20.60% · other public 0.05%

    Turnout: all 62.75% · promoters 81.72% · institutions 88.34% · other public 24.04%

  5. Ratification of remuneration to be paid to the Cost Auditors for FY 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 73.46% · promoters 99.97% · institutions 88.34% · other public 24.04%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Oct 2022, 1 resolution

The company's voting result (opens in a new tab)

  1. Ordinary Resoution for re-apppointment of Shri Rashesh C. Gogri (DIN:00066291) as the Managing Director of the Company.
    OrdinaryPromoters have an interest in it
    97.16% for2.84% against

    Against: promoters 0.00% · institutions 31.90% · other public 0.07%

    Turnout: all 50.13% · promoters 63.99% · institutions 89.29% · other public 21.48%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 4 Aug 2022, 7 resolutions

Present: 32 promoters and 54 others.The company's voting result (opens in a new tab)

  1. Adoption of Financial Statement (Standalone & Consolidated) for the Financial Year ended March 31, 2022 together with the Reports of the Directors and Auditors thereon
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.35% · other public 0.02%

    Turnout: all 69.62% · promoters 94.75% · institutions 87.74% · other public 24.22%

  2. Re-appointment of Shri Uday M. Patil (DIN: 01186406), who retires by rotation and being eligible, seeks re-appointment.
    OrdinaryPromoters have an interest in it
    92.11% for7.89% against

    Against: promoters 0.00% · institutions 99.15% · other public 0.08%

    Turnout: all 54.01% · promoters 69.49% · institutions 88.10% · other public 22.88%

  3. Approval to the Appointment of Shri Bhaskar N. Thorat (DIN:01293824) As an Independent Director of the Compnay.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 69.64% · promoters 94.75% · institutions 88.10% · other public 24.22%

  4. Approval to the Appointment of Smt Neha R. Gada (DIN:01642373) As an Independent Director of the Company
    Special
    95.81% for4.19% against

    Against: promoters 0.00% · institutions 68.03% · other public 0.03%

    Turnout: all 69.64% · promoters 94.75% · institutions 88.10% · other public 24.22%

  5. Approval to Shri Arun M. Patil to continue to hold office or Place of Office with Revised Remuneration.
    OrdinaryPromoters have an interest in it
    92.63% for7.37% against

    Against: promoters 0.00% · institutions 92.64% · other public 0.06%

    Turnout: all 54.01% · promoters 69.49% · institutions 88.10% · other public 22.88%

  6. Approval for giving Loan or Gurantee or Providing security under Section 185 0f the Companies Act 2013
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 69.64% · promoters 94.75% · institutions 88.10% · other public 24.22%

  7. Ratification of Remuneration to be Paid to the Cost Auditor
    Ordinary
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.35% · other public 0.03%

    Turnout: all 69.64% · promoters 94.75% · institutions 88.10% · other public 24.22%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 24 Nov 2021, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 69.67% · promoters 98.02% · institutions 85.48% · other public 19.81%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 26 Sep 2026, 3 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon.MoreLess
    3 for0 against
  • Approval to the Retirement of Shri Uday M. Patil (DIN: 01186406) who retires by rotation and has not offered himself for re-appointment as a Director of the Company.
    3 for0 against
  • Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Director of the Company.
    3 for0 against
  • Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Whole-time Director of the Company
    3 for0 against
  • Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Director of the Company.
    3 for0 against
  • Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Managing Director of the Company.
    3 for0 against
  • Re-appointment of Shri Harshit Manilal Savla (DIN: 00005340) as the Joint Managing Director of the Company.
    3 for0 against
  • Re-appointment of Shri Harit Pragji Shah (DIN: 00005501) as the Whole-time Director of the Company.
    3 for0 against
  • Re-appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company for the second term of 5 (five) years.
    3 for0 against
  • Re-appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company for the second term of 5 (five) years.
    3 for0 against
  • Re-appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director of the Company for the second term of 5 (five) years.
    3 for0 against
  • Approval to Shri Prakash Moreshwar Patil, a Related Party, to hold an Office or Place of Profit in the Company.
    Against Angel One Mutual Fund
    • Angel One Mutual FundGovernance & Transparency Concern: Proposed remuneration appears on higher side when considered with the remuneration Executive / Managing Directors. Basis of arriving at the proposed remuneration not adequately disclosed; hence, fairness of proposed remuneration cannot be ascertained.
    2 for1 against
  • Payment of Profit Related Commission to the Nonexecutive Directors.
    3 for0 against
  • Aarti Drugs Limited Performance Stock Option Plan 2026 (PSOP 2026).
    Against Angel One Mutual Fund, DSP Mutual Fund, ICICI Prudential Mutual Fund
    • Angel One Mutual FundInadequate disclosures on the Exercise Price / Pricing Formula, Governance and Transparency Concerns: The Scheme provides a broad range of Vesting period including provision of Acceleration of vesting period. Exercise Period may not be uniform across employees under the Scheme, including provisions for lapse of options even before expiry of exercise period without adequate rationale. Nomination & Remuneration Committee has been given discretion to determine the lock-in period without adequate rationale for the same. The proposed limit of maximum options per employee indicates a potential for excessive benefits to a single employee under the Scheme.
    • DSP Mutual FundPSOP 2026 has a pool size of 800,000 resulting in an overall dilution of ~0.9% on the expanded capital base. As per the plan the exercise price shall be determined by the Nomination and Remuneration Committee (NRC) and will not be lower than the face value : Rs. 10.0 per share. The exercise price may be different for employees falling under the same tranche. Further, the vesting of options is time based such that the options granted shall vest so long as the employee continues to be in the employment. The NRCmay prescribe achievement of any performance condition(s) for vesting.Stock options are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount. Issuance of stock options at a significant discount to market price does not align the interests of shareholders with those of employees unless the options vest based on clear performance based parameters. In case of PSOP 2026, the vesting is primarily linked to time based condition and NRC has the discretion to determine any additional performance conditions. Since vesting under PSOP 2026 is not mandatorily linked to performance criteria, we are unable to support the resolution
    • ICICI Prudential Mutual FundDue to the inadequate disclosure on the exercise price/ pricing formula, the AMC has voted against the resolution.
    0 for3 against
  • Grant of stock options under Aarti Drugs Limited Performance Stock Option Plan 2026 (PSOP 2026) to the Employees of the Subsidiary Companies, Group Companies and Associate Companies (Present or Future).MoreLess
    Against Angel One Mutual Fund, DSP Mutual Fund, ICICI Prudential Mutual Fund
    • Angel One Mutual FundInterlinked with resolution #14. Governance and Transparency Concerns: Interlinked to resolution #14. + Scheme proposed to be extended to Group Companies and Associate Companies without compelling reasons and no affirmation on cost re-imbursement provisions, if any.
    • DSP Mutual FundThe company proposes to extend the PSOP 2026 to eligible employees of its existing and future subsidiaries, associate and group companies. While we support the extension of the scheme to subsidiary company employees, we do not support extension of scheme to associate and holding companies. Further, our recommendation is linked to our view on resolution #14. We do not support this resolution.
    • ICICI Prudential Mutual FundThe AMC's view on the resolution is interlinked with the above resolution #14. Hence, the AMC has voted against the resolution.
    0 for3 against
  • Ratification of remuneration of Cost Auditors for FY 2026-27.
    2 for0 against
1 proposal not matched to one resolution
  • Ratification of remuneration of Rs. 4,00,000/- per annum plus tax as applicable and reimbursement of out of pocket expenses at actual to be paid to GMVP and Associates LLP, Cost Accountant (Firm Reg. No.:- 000910), being the Cost Auditor appointed by the Board of Directors based on the recommendations of the Audit Committee of the Company, for the conduct of the Audit of cost records and related books maintained by the Company, for the Financial Year 2026-27.MoreLess
    1 for0 against

Mutual fund votes, meeting of 24 Sep 2025, 6 fund houses

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the Reports of the Board of Directors' and the Auditors thereon.MoreLess
    6 for0 against
  • To appoint a Director in place of Shri Harshit Manilal Savla (DIN: 00005340), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    6 for0 against
  • Revision in the terms And conditions of appointment of Executive Directors.
    Against Angel One Mutual Fund, Groww Mutual Fund
    • Angel One Mutual FundProposed approval for revision in remuneration is clubbed for four executive directors which also includes the Director holding combined position of Managing Director and Board Chairperson and, such combined position may lead to concentration of power in the hands of single individual. The proposal also covers a Director who holds excessive time commitments in the form of two full-time positions.
    • Groww Mutual FundCompliant with law. Governance concern: Proposed approval for revision in remuneration is clubbed for four executive directors which also includes the Director holding combined position of Managing Director and Board Chairperson and, such combined position may lead to concentration of power in the hands of single individual. The proposal also covers a Director who holds excessive time commitments in the form of two full-time positions.
    4 for2 against
  • Appointment of Secretarial Auditor for the period of 5 Consecutive Financial Years.
    Against Angel One Mutual Fund, Groww Mutual Fund
    • Angel One Mutual FundDetails regarding previous auditors’remuneration not available; hence, it cannot be ascertained as to whether there is any material change in the proposed Audit fee or not.
    • Groww Mutual FundCompliant with law. No concern on the merits of proposed Auditors. Transparency Concern: Details regarding previous auditors’ remuneration not available; hence, it cannot be ascertained as to whether there is any material change in the proposed Audit fee or not.
    4 for2 against
  • Ratification of remuneration of Cost Auditors for FY 2025-26.
    6 for0 against
6 earlier meetings

Mutual fund votes, meeting of 20 Sep 2024, 4 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with the Reports of the Board of Directors¿ and the Auditors thereon.MoreLess
    4 for0 against
  • To appoint a Director in place of Shri Narendra Jagannath Salvi (DIN: 00299202), who is liable to retire by rotation and being eligible, offers himself for re-appointment
    4 for0 against
  • Re-appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director
    4 for0 against
  • Re-appointment of Shri Bhaskar Narayan Thorat (DIN: 01293824) as an Independent Direct
    4 for0 against
  • Re-appointment of Smt. Neha Rajen Gada (DIN: 01642373) as an Independent Director
    Against DSP Mutual Fund
    • DSP Mutual FundNeha Gada, 48, is the Founder of N R Gada and Associates, Chartered Accountants and Co-Founder of Dhhanish Advisors Private Limited . She has been on the board since May 2022 and attended all seven board meetings held in FY24. Although her reappointment meets statutory requirements, she serves as an Independent Director on the board of four listed companies including Aarti Drugs Limited. Given their full-time responsibilities, regulations allow whole time directors of listed companies to be independent directors in maximum of three listed companies. We believe that her responsibilities as the name partner of N R Gada & Associates are equivalent to a whole-time directorship. Therefore, the high number of directorships on listed companies are not in keeping with the spirit of the regulation.
    3 for1 against
  • Revision in the terms & conditions of appointment of Shri Uday Moreshwar Patil (DIN: 01186406), Executive Director of the Company
    Against Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNon-Compliant with SEBI LODR Regulations: Shareholder’s approval not sought for re-appointment. No major concern identified over the merits of appointee.
    0 for3 against
  • Ratification of remuneration of Cost Auditors for FY 2024-25
    4 for0 against
1 proposal not matched to one resolution
  • Approve revision in remuneration of Uday Patil (DIN: 01186406), from FY25 upto FY29
    1 for0 against

Mutual fund votes, meeting of 15 Jun 2024, 6 fund houses

  • Approval to the appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company.
    6 for0 against
  • Approval to the appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director of the Company.
    6 for0 against
  • Approval to the appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company.
    6 for0 against

Mutual fund votes, meeting of 26 Sep 2023, 5 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Financial Statement (Standalone & Consolidated) for the Financial Year ended March 31, 2023, together with the Reports of the Directors and Auditors thereon.
    5 for0 against
  • Re-appointment of Shri Harit P.Shah (DIN: 00005501), who retires by rotation and being eligible, seeks re-appointment.
    5 for0 against
  • Appointment of Gokhale & Sathe, Chartered Accountants as Statutory Auditors of the Company
    Against Motilal Oswal Mutual Fund, Nippon India Mutual Fund, SBI Mutual Fund
    • Motilal Oswal Mutual FundThough no concern on merits of the statutory Auditors, however, Non-Compliant with Regulation 36(5) of SEBI LODR as Proposed audit fee not disclosed.
    • Nippon India Mutual FundInadequate disclosure
    • SBI Mutual FundThe company proposes to appoint Gokhale & Sathe. as statutory auditors for five years from the conclusion of the 2023 AGM. They will be replacing Kirtane & Pandit LLP - appointed for four years as statutory auditors from the conclusion of 2019 AGM and retire at the conclusion of 2023 AGM. Gokhale & Sathe have been associated as the statutory auditors of Aarti Industries Limited and its group companies for over fifteen years: Aarti Drugs Limited is part of the same promoter group. We raise concerns over auditor independence and objectivity given the long and continued association with the promoter group. Therefore, we are unable to support Gokhale & Sathe’s reappointment as statutory auditors. The company has not disclosed the proposed audit fee, which is a regulatory requirement. The audit fees for FY23 stood at Rs. 1.4 mn (consolidated) and Rs. 1.10 mn (standalone) respectively. This is why we do not support the resolution.
    2 for3 against
  • Approval to Smt Richie Gandhi to continue to hold office or place of profit with revised Remuneration.
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundInsufficient information
    4 for1 against
  • Ratification of remuneration to be paid to the Cost Auditors for FY 2023-24
    4 for0 against
1 proposal not matched to one resolution
  • 5) Approve remuneration of Rs. 300,000 payable to GMVP & Associates LLP, cost auditors for FY24.
    1 for0 against

Mutual fund votes, meeting of 29 Oct 2022, 2 fund houses

  • Ordinary Resoution for re-apppointment of Shri Rashesh C. Gogri (DIN:00066291) as the Managing Director of the Company.
    2 for0 against

Mutual fund votes, meeting of 4 Aug 2022, 3 fund houses

  • Adoption of Financial Statement (Standalone & Consolidated) for the Financial Year ended March 31, 2022 together with the Reports of the Directors and Auditors thereon
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundNon-disclosure of latest financial statements of Subsidiaries on the website
    2 for1 against
  • Re-appointment of Shri Uday M. Patil (DIN: 01186406), who retires by rotation and being eligible, seeks re-appointment.
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundLow Attendance
    2 for1 against
  • Approval to the Appointment of Shri Bhaskar N. Thorat (DIN:01293824) As an Independent Director of the Compnay.
    3 for0 against
  • Approval to the Appointment of Smt Neha R. Gada (DIN:01642373) As an Independent Director of the Company
    3 for0 against
  • Approval to Shri Arun M. Patil to continue to hold office or Place of Office with Revised Remuneration.
    3 for0 against
  • Approval for giving Loan or Gurantee or Providing security under Section 185 0f the Companies Act 2013
    3 for0 against
  • Ratification of Remuneration to be Paid to the Cost Auditor
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundLow audit fees
    2 for1 against

Mutual fund votes, meeting of 24 Nov 2021, 7 fund houses

  • Appointment of Shri Ankit Vikram Paleja (DIN: 06975564) as an Independent Director of the Company.
    7 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Tax disputeCommissioner of CGST & C.ExSince 3 Aug 2024
    With respect to the previous disclosure, the captioned matter, along with the connected matters, the Hon’ble Supreme Court of India, vide its order (as informed to theExchange vide our communication dated August 10, 2026 with reference number ADL/SE/2026-27/37), dismissed the Special Leave Petition filed by the GST Department.MoreLess
    At the filing before: The Company received the Special Leave Petition (Civil) filed by the GST Department before the Hon’ble Supreme Court of India, challenging the judgment and order dated October 6, 2025, passed by the Hon’ble High Court in favour of the Company. The Company thereafter duly filed a Caveat Petition before the Hon’ble Supreme Court of India. The captioned matter, along with the connected matters, was pending before the Hon’ble Supreme Court of India for further arguments.MoreLess
  • Tax disputeOffice of Joint Commissioner of State Tax, Investigation-B, MumbaiSince 28 Jan 2025
    With respect to the GST-related dispute, as disclosed in the previous quarter: (1) the Appellate Authority passed the Order-in-Appeal, in respect of FY 2018–19, and the filing of an appeal before the GST Appellate Tribunal against the said order is currently under process; and (2) in respect of FY 2019–20, the personal hearing was attended. also the filing of additional written submissions was made. The matter is presently pending adjudication before the Appellate Authority.MoreLess
    At the filing before: With respect to the GST-related dispute, as disclosed in the previous quarter: (1) personal hearings in the appeal pertaining to FY 2018-19 were attended, and written submissions were filed before the Appellate Authority. The matter was pending adjudication before the Appellate Authority; and (2) an appeal against the order pertaining to FY 2019-20 was duly filed and admitted by the Appellate Authority.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Jun 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.